Assessment of mRNA splice variants by qRT-PCR

Methods in Molecular Biology

Volumn 1049, Issue , 2013, Pages 171-186

  Vargas, Ileabett M Echevarria ^a   Vivas Mejía, Pablo E ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Drug resistance; Ovarian cancer; Real time PCR; Small interference RNA; Splice variants; Survivin; SYBR green I based PCR

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; MESSENGER RNA; SMALL INTERFERING RNA; SURVIVIN; ISOPROTEIN; ORGANIC COMPOUND; SYBR GREEN I;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CELLULAR DISTRIBUTION; DNA SYNTHESIS; EXON; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; APOPTOSIS; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; OVARY TUMOR; PATHOLOGY; PROCEDURES; RNA SPLICING;

APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ORGANIC CHEMICALS; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 84881589028     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-547-7_13     Document Type: Article

References (19)

1. Cheung CH et al (2011) Investigation of survivin: The past, present and future. Front Biosci 16:952-961
2. Liguang Z et al (2007) Survivin expression in ovarian cancer. Exp Oncol 29:121-125
3. Ferrandina G et al (2005) Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters. Br J Cancer 92:271-277
4. Carrasco R et al (2011) Antisense inhibition of survivin expression as a cancer therapeutic. Mol Cancer Ther 20:221-232
5. Pennati M, Folini M, Zaffaroni N (2007) Targeting survivin in a cancer therapy: Fulfilled promises and open questions. Carcinogenesis 28:1133-1139
6. Vader G et al (2006) Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep 7:85-92
7. Sampath J, Pelus LM (2007) Alternative splice variants of survivin as potential targets in cancer. Curr Drug Discov Technol 4:174-191
8. Caldas H, Honsey LE, Altura RA (2005) Survivin 2α: A novel survivin splice variant expressed in human malignancies. Mol Cancer 4:11-19
9. Mahotka C et al (1999) Survivin-ΔEx3 and Survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-6102
10. Knauer SK et al (2007) The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 6:1502-1509
11. Mahotka C et al (2002) Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9:1334-1342
12. Stauber RH, Mann W, Knauer SK (2007) Nuclear and cytoplasmic survivin: Molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67:5999-6002
13. Vivas-Mejía PE et al (2011) Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer. Clin Cancer Res 17:3716-3726
14. Doolittle H, Morel A, Talbot D (2010) Survivin-directed anticancer therapies-a review of pre-clinical data and early-phase clinical trials. Eur Oncol 6:10-14
15. Ponchel F et al (2003) Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol 3:18
16. Lamendola DE et al (2003) Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line. Cancer Res 63:2200-2205
17. Thaker PH et al (2005) Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clin Cancer Res 11:4923-4933
18. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: Methods in molecular biology. Humana Press, Totowa, NJ, pp 365-386
19. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative Ct method. Nat Protoc 3:1101-1108